Clinical Trial Update: Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of Capecitabine [Phase 3]

View source ↗

Summary

Phase 3 trial comparing two sequencing strategies of capecitabine/erlotinib and gemcitabine for pancreatic cancer; current status/results are not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• ERLOTINIB (Erlotinib)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: PD Dr. med. Volker Heinemann | Conditions: Pancreatic Cancer | Phase 3 | Status: UNKNOWN